You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
Endometrial cancer, a malignancy of the uterine lining, is the fourth most common cancer among women in the United States and United Kingdom. One of its preconditions is sometimes polycystic ovary syndrome (PCOS), a hormonal condition in which ovarian follicles fail to develop completely, often leading to irregular menstrual cycles, obesity, and excess hairiness.
Another side effect of PCOS is insulin resistance and excessive insulin production. Over the years, as scientists used metformin to control those symptoms in women with the syndrome, they noted that its long-term use also improved ovulation and menstrual cycle regularity.
Because obesity, PCOS, and diabetes are linked to an increased risk of endometrial cancer, researchers at the Warwick Medical School at the University of Warwick decided to study the effect of metformin on endometrial cancer cells. They used sera on the cells that they derived from three sources: a control group and two groups of PCOS women: one that had received no metformin treatment and one that had.
They found that the cancer cells treated with a serum from the metformin-treated group spread at a 25 percent slower rate than cells treated with non-metformin-affected sera.
The U.K. researchers said that while the results open the door to a potential metformin-based therapy for endometrial cancer, there still needs to be a comprehensive randomized trial to determine its full potential.
The research paper was published in The Journal of Clinical Endocrinology & Metabolism and is titled "Metformin Treatment Exerts Antiinvasive and Antimetastatic Effects in Human Endometrial Carcinoma Cells."
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.